Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esther Conde

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
International Journal of Cancer|February 13, 2013
Determining the profiles and parameters for gene amplification testing of growth factor receptors in lung cancerEva Pros, Sylvie Lantuejoul, Lydia Sanchez-Verde, et al.
Lung Cancer (Amsterdam, Netherlands)|December 25, 2025
Optimizing communication for ultrafast lung cancer biomarker testing: the UTOPIA pilot studySusana Hernandez, Esther Conde, Marta Alonso, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 12, 2025
PD-L1 expression scoring using artificial intelligence algorithms in non-small cell lung cancer harbouring ROS1 fusions: potential clinical-biological significanceLuis Fernando García, Esther Conde, Susana Hernandez, et al.
Histopathology|August 18, 2017
Aligning digital CD8<sup>+</sup> scoring and targeted next-generation sequencing with programmed death ligand 1 expression: a pragmatic approach in early-stage squamous cell lung carcinomaEsther Conde, Alejandra Caminoa, Carolina Dominguez, et al.
Journal of Fungi (Basel, Switzerland)|June 23, 2022
Epidemiology of Clinical Sporotrichosis in the Americas in the Last Ten YearsRigoberto Hernández-Castro, Rodolfo Pinto-Almazán, Roberto Arenas, et al.
Clinical Chemistry|January 12, 2017
Identification of <i>ALK</i>, <i>ROS1</i>, and <i>RET</i> Fusions by a Multiplexed mRNA-Based Assay in Formalin-Fixed, Paraffin-Embedded Samples from Advanced Non-Small-Cell Lung Cancer PatientsNoemí Reguart, Cristina Teixidó, Ana Giménez-Capitán, et al.
Pharmaceutics|October 23, 2021
<i>Candida glabrata</i> Antifungal Resistance and Virulence Factors, a Perfect Pathogenic CombinationMaría Guadalupe Frías-De-León, Rigoberto Hernández-Castro, Esther Conde-Cuevas, et al.
Archives of Pathology & Laboratory Medicine|June 4, 2023
Efficient Identification of Patients With NTRK Fusions Using a Supervised Tumor-Agnostic ApproachSusana Hernandez, Esther Conde, Aida Molero, et al.
Plos One|September 24, 2014
Accurate identification of ALK positive lung carcinoma patients: novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistryEsther Conde, Ana Suárez-Gauthier, Amparo Benito, et al.
Lung Cancer (Amsterdam, Netherlands)|June 27, 2026
Limited predictive value of PD-L1 TPS for pathological response in NSCLC is not attributable to interobserver variabilityKonrad Steinestel, Lena-Maria Löwer-Kiem, Francesca Ambrosi, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
International Journal of Cancer|February 13, 2013
Determining the profiles and parameters for gene amplification testing of growth factor receptors in lung cancerEva Pros, Sylvie Lantuejoul, Lydia Sanchez-Verde, et al.
Lung Cancer (Amsterdam, Netherlands)|December 25, 2025
Optimizing communication for ultrafast lung cancer biomarker testing: the UTOPIA pilot studySusana Hernandez, Esther Conde, Marta Alonso, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 12, 2025
PD-L1 expression scoring using artificial intelligence algorithms in non-small cell lung cancer harbouring ROS1 fusions: potential clinical-biological significanceLuis Fernando García, Esther Conde, Susana Hernandez, et al.
Histopathology|August 18, 2017
Aligning digital CD8<sup>+</sup> scoring and targeted next-generation sequencing with programmed death ligand 1 expression: a pragmatic approach in early-stage squamous cell lung carcinomaEsther Conde, Alejandra Caminoa, Carolina Dominguez, et al.
Journal of Fungi (Basel, Switzerland)|June 23, 2022
Epidemiology of Clinical Sporotrichosis in the Americas in the Last Ten YearsRigoberto Hernández-Castro, Rodolfo Pinto-Almazán, Roberto Arenas, et al.
Clinical Chemistry|January 12, 2017
Identification of <i>ALK</i>, <i>ROS1</i>, and <i>RET</i> Fusions by a Multiplexed mRNA-Based Assay in Formalin-Fixed, Paraffin-Embedded Samples from Advanced Non-Small-Cell Lung Cancer PatientsNoemí Reguart, Cristina Teixidó, Ana Giménez-Capitán, et al.
Pharmaceutics|October 23, 2021
<i>Candida glabrata</i> Antifungal Resistance and Virulence Factors, a Perfect Pathogenic CombinationMaría Guadalupe Frías-De-León, Rigoberto Hernández-Castro, Esther Conde-Cuevas, et al.
Archives of Pathology & Laboratory Medicine|June 4, 2023
Efficient Identification of Patients With NTRK Fusions Using a Supervised Tumor-Agnostic ApproachSusana Hernandez, Esther Conde, Aida Molero, et al.
Plos One|September 24, 2014
Accurate identification of ALK positive lung carcinoma patients: novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistryEsther Conde, Ana Suárez-Gauthier, Amparo Benito, et al.
Lung Cancer (Amsterdam, Netherlands)|June 27, 2026
Limited predictive value of PD-L1 TPS for pathological response in NSCLC is not attributable to interobserver variabilityKonrad Steinestel, Lena-Maria Löwer-Kiem, Francesca Ambrosi, et al.
Pageof 8